Cellectis: An 'All Or Nothing' Pivot To In-Vivo Gene Editing Is Worth Monitoring

Cellectis pivots to in vivo gene editing, exiting ex-vivo CAR-T programs due to shrinking commercial opportunities. Read why ...

Vapor-phase synthesis of MXenes could expand their technological applications

MXenes are two-dimensional nanomaterials first synthesized at Drexel University in 2011. They have been recognized by the ...
Drexel University

New Process for Making MXenes Via Vapor-Phase Synthesis Could Expand Its Technological Applications

MXenes are two-dimensional nanomaterials first synthesized at Drexel University in 2011. They have been recognized by the ...

40-year-old prediction of how plastics 'mix' confirmed for the first time

A "mixing" phenomenon between plastic layers that had been predicted only in theory for 40 years has now been experimentally ...
Interesting Engineering

2.5-GW Texas gas-nuclear plant advances as Blue Energy submits filing for 300-MW SMR

Blue Energy reaches a key milestone by filing the first part of an NRC construction permit for a BWRX-300 reactor.
The American Journal of Managed Care

HARMONi-2 Results Could Disrupt the Harmonious NSCLC Treatment Landscape

The therapeutic landscape for non–small cell lung cancer (NSCLC) has been relatively stable since the 2016 approval of pembrolizumab, but results presented at the 2024 World Conference on Lung Cancer ...
C&EN

Polarity switch enables easier alkylation

Sequential decarboxylation lets chemists attach electron-rich groups to carbon-carbon double bonds ...